Minjie Feng

Minjie Feng has extensive experience in the pharmaceutical industry, with a focus on oncology. Starting in 2005, Minjie worked as a Scientific Associate at Novartis Institute for Biomedical Research before transitioning to roles at Novartis Oncology, where they served as a Clinical Project Associate and held various positions as a Senior Clinical Manager and Clinical Trial Leader. In 2014, Minjie joined Bayer Pharmaceuticals as an Associate Director, overseeing oncology study management. They then joined Regeneron Pharmaceuticals as a Senior Manager in Oncology Clinical Science before moving to Bristol Myers Squibb as an Associate Director and later Blueprint Medicines as the Director of Clinical Science. Minjie's expertise lies in clinical science and study management, particularly within the field of oncology.

Minjie Feng earned a Bachelor of Science degree in Biophysics from Fudan University in 1999. They later completed a Master of Science in Biomedical Engineering from Rutgers University in 2004. In 2011, they obtained an MBA with a focus on Pharmaceutical Management from Fairleigh Dickinson University.